作为肺结核病宿主导治疗的阿齐思罗米:一个随机试验试验
Bart G J Dekkers1, Huib A M Kerstjens2, Helene W Breisnes3,4
1Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
The Journal of infectious diseases
|February 11, 2025
概括
在标准结核病治疗中添加的阿齐思罗米可以降低患者的炎症标志物. 这种辅助疗法似乎是安全的,有助于解决结核病的全身和肺炎.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 研究结核病 (TB) 的宿主导疗法,以调节免疫反应和减少炎症.
- 像阿齐思罗米这样的宏类药物除了具有抗菌作用外,还具有抗炎和免疫调节性质.
- 研究了阿齐思罗米提高炎症解消和减少结核病患者组织循环的潜力.
研究的目的:
- 评估阿齐思罗米作为辅助疗法是否能改善肺结核炎症的炎症解决.
- 评估阿齐思罗米对全身和肺炎炎症标志物的影响.
- 为了确定阿齐思罗米辛是否会影响结核病患者的细胞外矩阵周转.
主要方法:
- 进行了一项开放标签,随机对照试验.
- 药物敏感性肺结核的成年患者在28天内接受了标准治疗,服用或不服用阿齐思罗米 (每天250毫克).
- 在血液和唾液中测量了炎症和组织周转的生物标志物.
主要成果:
- 阿齐思罗米显著增强了血液中干扰素γ诱导的蛋白-10 (IP-10) 的降低.
- 用阿齐思罗米治疗导致唾液中性粒细胞,中性粒细胞弹性酶和转化生长因子-β的显著减少.
- 阿齐思罗米还显著降低了血液中的原降解标志物C4M.
- 在标准护理中添加阿齐思罗米被发现是安全的.
结论:
- 在标准结核病治疗中添加阿齐思罗米有助于减少肺结核中的中性恋炎症.
- 阿齐思罗米作为治疗结核病炎症的辅助疗法具有前景.
- 进一步的研究可能会探讨阿齐思罗米在改善结核病患者的临床结果中的作用.
更多相关视频
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis IV
132
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
132
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis III
296
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
296


